Table of Contents The link between metabolism and neurodegeneration How GLP-1 receptor agonists may affect the brain Current clinical evidence in Parkinsons disease Practical implications for clinicians FAQs Understanding the Metabolic Connection in Parkinsons Disease Parkinsons disease has traditionally been viewed as a movement disorder caused by dopamine neuron loss in the substantia nigra
Coverage depends on your health plan and your provinces Pharmacare policies
Cincinnati clients use these insights to build a personalized path forward
It makes up the majority of the human body's antioxidant defense system
Tracking food intake, increasing protein consumption, incorporating strength training, improving sleep quality, managing stress, and staying consistent with treatment can all help
GLP-1RAs ameliorate ROS-induced or hyperglycemia-induced apoptosis through modulating IL-6 production and ER stress-induced by hyperhomocysteinemia, via stromal cell-derived factor (SDF)-1/C-X-C motif receptor 7 (CXCR7) -AMPK/p38-MAPK axis [113-115]